... a regenerative biotechnology company with a lifesaving mesenchymal ... and an Operations and Order Fulfillment Center located in San Antonio, ...
News
- Direct Biologics Reveals Successful Outcomes from EXIT COVID-19 Phase II Clinical Trial | BioSpace
- Direct Biologics Reveals Successful Outcomes from EXIT COVID-19 Phase II Clinical Trial
PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC) derived extracellular vesicle ...
- EVO ICL UNITED STATES LAUNCH: First group of patients race to Parkhurst Nuvision in ...
San Antonio, Texas , April 05, 2022 (GLOBE NEWSWIRE) -- With the recent FDA approval of EVO Visian® ICL (referred to as "EVO"), patients are ...
- NIH funds new tuberculosis research advancement centers
Texas Biomedical Research Institute, San Antonio Principal Investigator: Larry Schlesinger, M.D.. Grant P30AI168439-01.
- San Antonio faces Minnesota on 3-game win streak | Basketball | trib.com
San Antonio Spurs (34-45, 10th in the Western Conference) vs. Minnesota Timberwolves (45-35, seventh in the Western Conference)